DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online groups, photo galleries and blogs
A Survey Study of Neuropsychiatric Complaints in Patients With Graves’ Disease: A Reassessment of Self-Reported Symptoms and Current Practice 20 Years Later: Graves’ Disease And Thyroid Foundation
It has been estimated that 1 in 200 people or 1.6 million individuals suffer from Graves’ disease in the United States alone. Despite this, the United States Preventative Services Task Force concluded that there is insufficient evidence to support for regular screening for thyroid dysfunction in non-pregnant, asymptomatic adults. The task force specifically cited a lack of prospective research in their decision making. However, a number of investigation, including a study conducted by Stern and colleagues in 1996, suggest that symptoms associated with Graves disease are multidimensional and may include neuropsychiatric, as well as somatic symptoms that may be difficult to detect, but may be life threatening.
The present investigation represents an extensive twenty-year follow-up to the Stern et al. survey study conducted over 20 years ago. In addition to examining the neuropsychiatric complaints of Graves’ disease patients, the current investigation also examined issues related to the diagnosis and treatment of the disorder. Research conducted by our group suggests that Graves’ disease continues to be misdiagnosed at an alarming rate and that access to healthcare and health information, as well as inadequate routine screening, may play a role in misdiagnosis and a delay in treatment.

Related Content
-
Evidence & EducationPsychological Symptoms and Thyroid DisordersPeople with thyroid disorders often have...
-
Evidence & EducationImpaired Decision Making Under Risky Conditions in the Acute Phase of Graves’ ThyroitoxicosisThe patients with Graves' thyroitoxicosi...
-
Evidence & EducationQuality of Life and Neuropsychiatric Disorders in Patients With Graves’ Orbitopathy: Current ConceptsGraves' disease (GD) is an autoimmune ch...
-
Evidence & EducationThe Impact of Graves’ Disease and Its Treatment on Handwriting CharacteristicsBackground: Thyroid hormones are crucia...
-
Evidence & EducationStructural Brain Changes in Graves’ Hyperthyroidism may be of Autoimmune OriginIn Graves’ disease (GD), brain-derived...
-
People & PlacesThe British Thyroid FoundationThe British Thyroid Foundation (BTF) is ...
-
People & PlacesThyroid Eye Disease Charitable TrustThyroid Eye Disease Charitable Trust (TE...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.